Skip to main content
. 2022 Dec 31;15(1):141. doi: 10.3390/pharmaceutics15010141

Table 3.

Cytostatic activity of peptide/drug conjugates on MCF-7 and MDA-MB-231.

Conjugate IC50 ±SD (µM) a
MCF-7 MDA-MB-231
Dabcyl-AMBA-Arg-Arg-Arg-Arg-Lys(DauSuc) 10.3 ± 5.0 10.1 ± 6.0
Dabcyl-PABA- Arg-Arg-Arg-Arg-Lys(DauSuc) 17.7 ± 1.2 14.3 ± 1.1
Dabcyl-NAPH- Arg-Arg-Arg-Arg-Lys(DauSuc) 15.0 ± 4.2 16.6 ± 0.5
Dabcyl-Trp-Arg-Arg-Arg-Arg-Lys(DauSuc) b 26.4 ± 4.2 18.0 ± 6.7
DauSuc-Arg8 b 14.4 ± 0.2 19.5 ± 0.4
Dabcyl-AMBA-Arg-Arg-Arg-Arg-Lys(MTX) 11.8 ± 6.9 19.2 ± 7.1
Dabcyl-PABA- Arg-Arg-Arg-Arg-Lys(MTX) 18.6 ± 3.3 16.8 ± 4.7
Dabcyl-NAPH- Arg-Arg-Arg-Arg-Lys(MTX) 14.8 ± 2.5 16.9 ± 2.8
Dabcyl-AMBA-Arg-Arg-Arg-Arg-Lys(GFLG-E5-MTX) 8.0 ± 2.4 16.3 ±0.7
Dabcyl-Trp-Arg-Arg-Arg-Arg-Lys(MTX) b 36.9 ± 3.0 7.4 ± 2.2
MTX-Arg8 c >100 >100
DauSuc d 24.5 ± 7.1 >100
MTX c 0.8 ± 0.3 >100

a The cells were incubated with the compound for 3 h, and subsequently cultured in serum containing medium for 3 days.The IC50 values were determined by MTT assay as described in the text. Standard deviation values (SD) are also presented. b From the literature [33], c From the literature [6] and d From the literature [32].